St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
NCT Number: NCT02154555
Chronic rhinosinusitis (CRS) is a common sinus and nasal condition affecting more than 33 million Americans. The treatment of CRS typically begins with maximal medical therapy however, when this fails to improve patient symptoms, surgical intervention is considered. Endoscopic sinus surgery (ESS) is a well-established treatment for refractory CRS with approximately 600,000 sinus surgeries performed annually in the United States alone. Despite the success of this intervention, up to 26% of patients experience complications following surgery, including middle meatal (MM) synechiae, edema, polyp recurrence, and middle turbinate lateralization. Currently, there is no consensus as to the postoperative care regime that is most effective at minimizing or preventing these potential complications. Therefore there is need for further study into the role of debridement, examining patients undergoing endoscopic sinus surgery while concurrently addressing the potential confounders of maximal medical therapies in the postoperative setting.
This prospective, randomized, single-blind, controlled study design will investigate the efficacy of postoperative debridement following ESS. Patients who have undergone ESS will have one nare randomized to debridement and the other to no debridement at the first week post-operative visit. In this way, the patients will act as their own controls in order to account for inter-patient variability in disease severity. The primary outcome will assess synechiae formation attributed to ESS. Secondary outcomes will include pain (side-specific) attributed to the debridement procedure as well as comparing pre and post endoscopy scores and SNOT-22 questionnaire responses.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toronto, Ontario, M5B 1W8, Canada
The significant heterogeneity present in the current literature regarding the use of postoperative debridement warrants additional studies that document postoperative protocols and use universally accepted endoscopy scores in order to consistently track patient outcomes. Further investigation into the efficacy of postoperative debridement is especially interesting with the potential benefits of further reduced synechiae formation and edema. Conversely, if objective evidence fails to demonstrate benefit of postoperative debridement, there could be significant cost and time saving for healthcare professionals in removing this therapy from the postoperative protocols.
We hypothesize that postoperative debridement will have a significant effect on reducing the rates of synechiae formation. In addition, we hypothesize that this improvement in synechiae development will also be matched by improvements in postoperative endoscopic sinus scoring, and patient's overall symptoms at 1 and 3 months postoperatively.
This study can clarify the efficacy of postoperative debridement and the potential benefits of further reduced synechiae formation and edema, and thus decrease the rates of complication and revision surgery. Conversely, if objective evidence fails to demonstrate benefit of postoperative debridement, there could be significant cost and time saving for healthcare professionals in removing this therapy from the postoperative protocols.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
post-operative debridement at 1 week follow-up visit
Time frame: 1 week, 1 month, and 3 months after surgery
adhesions, scarring between middle turbinate and lateral nasal wall
Time frame: before surgery at clinical visit when consent for surgery is obtained (within 9 month period before surgery)
Time frame: 1 week after surgery
rated for each sinonasal cavity
Time frame: before surgery at clinical visit when consent for surgery is obtained (within 9 month period before surgery)
22-item sinonasal outcome test (SNOT-22) questionnaire score
Time frame: 1 month after surgery
rated for each sinonasal cavity
Time frame: 3 months after surgery
rated for each sinonasal cavity
Time frame: 1 week after surgery
Time frame: 1 month after surgery
Time frame: 3 months after surgery
Time frame: 1 week after surgery
22-item sinonasal outcome test (SNOT-22) questionnaire score
Time frame: 1 month after surgery
22-item sinonasal outcome test (SNOT-22) questionnaire score
Time frame: 3 months after surgery
22-item sinonasal outcome test (SNOT-22) questionnaire score
Time frame: before surgery at clinical visit when consent for surgery is obtained (within 9 month period before surgery)
rated for each sinonasal cavity
Unity Health Toronto
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07470242
Chronic Rhinosinusitis
Pusan, South Korea
View Trial DetailsNCT04117646
Chronic Rhinosinusitis, Fistula
Paris, France
View Trial DetailsNCT07242040
Chronic Rhinosinusitis, Cognition Disorders
Cairo, Egypt
View Trial DetailsNCT05198518
Chronic Rhinosinusitis, Neurologic Manifestations
New York, United States
View Trial Details